DANA DUDLEY: Open Payments
NPI 1205410230 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,181 in 216 payments from 50 companies in 2025. Trend: 2023 $3,874 · 2024 $5,219 · 2025 $5,181
Food & beverage: $4,197Long term medical supply or device loan: $1,016
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $1,375 |
| Daiichi Sankyo Inc. | 21 | $430 |
| AstraZeneca Pharmaceuticals LP | 18 | $366 |
| Merck Sharp & Dohme LLC | 13 | $268 |
| PFIZER INC. | 11 | $241 |
| Janssen Biotech, Inc. | 10 | $187 |
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $155 |
| Stemline Therapeutics Inc. | 5 | $123 |
| ARRAY BIOPHARMA INC | 7 | $90 |
Products named: KISQALI, Enhertu, KEYTRUDA, Fabhalta, OPDIVO, Nubeqa, DATROWAY, SCEMBLIX.
Industry payments across SC — which companies pay providers there.
